The review concluded that less-invasive options for abnormal uterine bleeding carried a significant risk of re-treatment and hysterectomy carried the highest risk of adverse events. These conclusions are based on a small number of heterogeneous studies and their reliability is uncertain.
To compare hysterectomy with less invasive alternatives for abnormal uterine bleeding.
Searching
MEDLINE was searched from 1950 to January 2011 for relevant studies in English. Search terms were reported. Bibliographies of retrieved articles were handsearched to identify further relevant evidence.
Study selection
Randomised controlled trials (RCTs) were eligible for inclusion if they compared hysterectomy with endometrial ablation, levonorgestrel intrauterine system or medical therapies for abnormal uterine bleeding caused by presumed ovulatory disorders or endometrial haemostatic dysfunction. Studies needed to report an outcome of interest: bleeding, quality of life, pain, sexual health, satisfaction, need for subsequent surgery and adverse events.
In included studies, mean age of participants (where reported) ranged from 40 to 46. The most commonly used intervention was total abdominal hysterectomy, followed by total vaginal hysterectomy and laparoscopic approach. Most comparative interventions used resectoscopic methods of endometrial ablation; one comparator arm used medical therapy.
The authors did not state how many reviewers selected studies for inclusion.
Assessment of study quality
Methodologic quality was assessed using a system modified from the Agency for Healthcare Research and Quality. Included studies were rated as (A) good, (B) fair or (C) poor based on the likelihood of bias and completeness of reporting. Grades could vary by outcome within each study. The overall strength of evidence for each outcome was rated as high, moderate, low or very low based on the GRADE system. It was not clear how many reviewers performed the assessment.
Data extraction
Key study data were extracted by one reviewer and checked by a second, with discrepancies resolved by consensus among review group members. Reported adverse events were classified as major or minor.
